Clinical Trial
doi: 10.1001/archpsyc.1990.01810150088014.
Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity
- PMID: 1968330
- DOI: 10.1001/archpsyc.1990.01810150088014
Item in Clipboard
Clinical Trial
Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity
Arch Gen Psychiatry.
1990 Mar.
No abstract available
Comment on
-
Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.Arch Gen Psychiatry. 1989 Jan;46(1):20-2. doi: 10.1001/archpsyc.1989.01810010022003. Arch Gen Psychiatry. 1989. PMID: 2562914
Similar articles
-
Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").J Neurochem. 1990 Jan;54(1):14-22. doi: 10.1111/j.1471-4159.1990.tb13277.x. J Neurochem. 1990. PMID: 1967141 Review. No abstract available.
-
Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.Neurosci Lett. 1989 Sep 25;104(1-2):178-82. doi: 10.1016/0304-3940(89)90351-0. Neurosci Lett. 1989. PMID: 2573011
-
The MDMA-neurotoxicity controversy: implications for clinical research with novel psychoactive drugs.J Nerv Ment Dis. 1992 Jun;180(6):355-6. doi: 10.1097/00005053-199206000-00003. J Nerv Ment Dis. 1992. PMID: 1350614 No abstract available.
-
Structure-activity relationships of MDMA-like substances.NIDA Res Monogr. 1989;94:1-29. NIDA Res Monogr. 1989. PMID: 2575223 Review. No abstract available.
-
'Ecstasy': a human neurotoxin?Arch Gen Psychiatry. 1989 Feb;46(2):191. doi: 10.1001/archpsyc.1989.01810020093015. Arch Gen Psychiatry. 1989. PMID: 2563326 No abstract available.
Cited by
-
Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").Psychopharmacology (Berl). 1995 Jun;119(3):247-60. doi: 10.1007/BF02246288. Psychopharmacology (Berl). 1995. PMID: 7675958 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
